Akorn to acquire Hi-Tech Pharmacal
Akorn Inc. plans to acquire Hi-Tech Pharmacal Co. for $640 million in a move to expand its eye drug portfolio to oral liquids and ointments. Akorn said Tuesday that the all-cash deal will make it the third-largest U.S.